Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 10:42 PM
Ignite Modification Date:
2025-12-25 @ 8:13 PM
NCT ID:
NCT03818035
Group ID:
EG002
Title:
Group 2b: Guselkumab 100 mg Q16W
Description:
Super responders (PASI score = 0 at Week 20 and Week 28) who completed study Part 1, were randomized to receive guselkumab 100 mg SC injection every 16 weeks (Q16W) dosing regimen at Weeks 36 and 52. To maintain the study blind, participants were administered placebo SC injection at Weeks 28, 44 and 60. Participants were followed from Week 28 till Week 68 or early termination prior to Week 68.
Deaths Number Affected:
0
Deaths Number At Risk:
None
Serious Number Affected:
6
Serious Number At Risk:
149
Other Number Affected:
103
Other Number At Risk:
149
Study:
NCT03818035
Results Section:
NCT03818035
Adverse Events Module:
NCT03818035